⌘K

Home/Filings/4/0001415889-23-004273

4//SEC Filing

Grimaud Brett A. 4

Accession 0001415889-23-004273

CIK 0001583107other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:35 PM ET

Size

4.5 KB

Accession

0001415889-23-004273

Insider Transaction Report

Form 4

Period: 2023-03-01

Theravance Biopharma, Inc.TBPH

Grimaud Brett A.

SVP, GEN COUNSEL AND SECRETARY

Transactions

Award
Ordinary Shares
2023-03-01+75,000→ 304,958 total

Documents

1 file

4
form4-03042023_010337.xmlPrimary

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1

filerCIK 0001966698

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 8:35 PM ET
Size: 4.5 KB

View on SEC.gov